Improving Ultrasound Based Prediction of Delivery Mode
Ultrasound Prediction of Delivery Mode: Can the First Stage Prediction Model be Further Improved?
1 other identifier
observational
240
1 country
1
Brief Summary
The progress of labour is traditionally determined by regular vaginal examinations (VEs) to assess the cervix (neck of the womb) and the baby's head position. Such examinations can be uncomfortable and risk causing infection to the baby or mother's womb. The findings are subjective, can be unreliable and cannot be recorded for later review and analysis. The novel, non-intrusive "transperineal ultrasound" technique has been developed utilising existing scanning machines normally found on a delivery unit, with the ultrasound probe placed outside the woman's vagina. This allows objective, recordable measurements creating images that can be captured and stored electronically. This is a prospective longitudinal observational cohort study in nulliparous term (37-42 weeks) labouring women. This study aims to improve the prediction of intrapartum Caesarean Delivery (ICD). The study contains ultrasound and clinical assessments: Transabdominal Ultrasound to measure: Umbilical and Middle Cerebral Artery Doppler, fetal head position and Amniotic Fluid Index (AFI). Transperineal Ultrasound to assess: Head Perineum Distance (HPD), Caput Succedaneum and moulding. Digital vaginal examination by a caregiver: to measure cervical dilatation. Primary outcome:
- Mode of delivery Secondary outcome:
- Time to delivery Neonatal outcomes:
- Apgar score, cord pH level, gender, fetal birth weight, neonatal unit admission within 24 hours, neonatal morbidity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 3, 2020
CompletedFirst Submitted
Initial submission to the registry
November 12, 2020
CompletedFirst Posted
Study publicly available on registry
November 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedSeptember 5, 2021
September 1, 2021
5 years
November 12, 2020
September 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intrapartum Caesarean delivery (ICD)
Number of participants who delivered by Caesarean section
3 years
Secondary Outcomes (1)
Time to delivery (length of labour of onset of the first stage to the completion of the second stage).
12-24 hours
Interventions
SCAN LABOURING WOMEN BY ULTRASOUND
Eligibility Criteria
Recruitment will start upon approval of the study. The infrastructure, research fellow, ultrasound machines, and the database are already in place, which ensure that the study can start promptly upon approval, without affecting or compromising routine clinical service provision. We aim to recruit minimum number according to the following calculations: In the labour prediction model, there are approximately 12 variables with 10 patients needed per variable and an approximate 25% Caesarean section rate (the primary outcome) in the UK currently. Practical calculation: 12 x 10 x (100/25) = 480 patients For predictive modelling, 480 patients minimum are required (37- 42 weeks). We have recruited 269 patients in the previous study, therefore, approximately 211 fully evaluable patients will be needed. We intend to recruit 240 participants to allow approximately 10% incomplete data/study withdrawals
You may qualify if:
- Aged 18-44.
- Cephalic presentation.
- Nulliparous.
- Singleton.
You may not qualify if:
- Younger than 18 years.
- Life-threatening maternal or fetal compromise needing immediate medical attention and/or delivery.
- Women who in the opinion of the researcher are unable to give fully informed consent to the study.
- Non-cephalic presentations.
- Multiple pregnancies.
- Multiparous patients.
- Not in established labour
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Imperial college NHS Trust Queen Charlotte and Chelsea Hospital
London, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2020
First Posted
November 19, 2020
Study Start
February 3, 2020
Primary Completion
February 1, 2025
Study Completion
February 1, 2025
Last Updated
September 5, 2021
Record last verified: 2021-09